🇺🇸 FDA
Patent

US 6884871

Isolation and use of tissue growth-inducing Frzb protein

expired A61KA61K38/00A61K48/00

Quick answer

US patent 6884871 (Isolation and use of tissue growth-inducing Frzb protein) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61K48/00